ImmunoGen Inc (IMGN)
US45253H1014 - Common Stock
| MRQ (2023-9-30) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 605.50M | 275.10M | 478.80M | 293.90M | 176.20M | |||
| Receivables | 137.20M | 18.00M | 13.90M | 22.50M | 27.20M | |||
| Inventories | 5.50M | N/A | N/A | N/A | N/A | |||
| Other Current Assets | 18.70M | 11.00M | 7.30M | 7.90M | 5.40M | |||
| Total Current Assets | 766.90M | 304.10M | 500.00M | 324.30M | 208.90M | |||
| Non-Current Assets | ||||||||
| PPE Net | 12.80M | 14.60M | 17.10M | 19.80M | 22.60M | |||
| Other Non-Current Assets | 42.40M | 30.20M | 8.70M | 11.00M | 3.80M | |||
| Total Non-Current Assets | 55.20M | 44.80M | 25.80M | 30.80M | 26.40M | |||
| TOTAL ASSETS | 822.10M | 348.90M | 525.80M | 355.10M | 235.30M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | 9.40M | 8.70M | 6.10M | 2.10M | N/A | |||
| Accrued Expenses | 63.20M | 54.00M | 32.10M | 37.10M | 25.90M | |||
| Accounts Payable | 24.90M | 45.40M | 18.40M | 9.50M | 9.90M | |||
| Other Current Liabilities | 37.20M | 13.90M | 44.40M | 73.60M | 41.60M | |||
| Total Current Liabilities | 134.70M | 121.90M | 100.90M | 122.30M | 77.40M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 88.60M | 23.40M | 35.00M | 41.10M | 84.30M | |||
| Other Non-Current Liabilities | 37.30M | 47.80M | 64.30M | 102.10M | 149.60M | |||
| Total Non-Current Liabilities | 125.80M | 71.20M | 99.30M | 143.20M | 234.00M | |||
| TOTAL LIABILITIES | 260.50M | 193.10M | 200.20M | 265.50M | 311.40M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -1.71B | -1.69B | -1.47B | -1.33B | -1.29B | |||
| Additional Paid In Capital | 2.27B | 1.85B | 1.79B | 1.42B | 1.21B | |||
| Common Shares | 2.40M | 2.30M | 2.20M | 2.00M | 1.50M | |||
| Other Shareholders' Equity | N/A | N/A | 325.59M | N/A | N/A | |||
| Shares Outstanding | 265.80M | 226.00M | 220.40M | 195.00M | 150.10M | |||
| Tangible Book Value per Share | 2.11 | 0.69 | 1.48 | 0.46 | -0.51 | |||
| Total Shareholders' Equity | 561.60M | 155.80M | 325.60M | 89.60M | -76.10M | |||
| TOTAL LIABILITIES AND EQUITY | 822.10M | 348.90M | 525.80M | 355.10M | 235.30M | |||
| Statistics | ||||||||
| Debt/Equity | 0.16 | 0.15 | 0.11 | 0.46 | -1.11 | |||
| Current Ratio | 5.69 | 2.49 | 4.96 | 2.65 | 2.70 | |||
| Return On Assets (ROA) | -8.94% | -63.89% | -26.49% | -12.50% | -44.24% | |||
| Return On Equity (ROE) | -13.09% | -143.07% | -42.78% | -49.55% | N/A | |||
All data in USD